EEG Topography and Tomography (LORETA) in Diagnosis and Pharmacotherapy of Depression

Earlier investigations suggested an involvement of the right hemisphere and the left prefrontal cortex (PFC) in the pathogenesis of depression. This paper presents our own electroencephalographic (EEG) topography and low-resolution brain electromagnetic tomography (LORETA) data obtained in unmedicated depressed patients, and the effects of two representative drugs of non-sedative and sedative antidepressants, i.e., citalopram (CIT) and imipramine (IMI), as compared with placebo in normal subjects. Sixty female menopausal syndrome patients with the diagnosis of a depressive episode without psychotic symptoms as well as 30 healthy controls were investigated. Concerning the effects of antidepressants, normal healthy subjects received single oral doses of 20 mg CIT, 75 mg IMI and placebo p.o. A 3-min vigilance-controlled EEG and a 4-min resting EEG was recorded pre- and post-drug administration and analyzed by means of EEG mapping and LORETA. In the EEG mapping, depressed patients demonstrated a decrease in absolute power in all frequency bands, an augmentation of relative delta/theta and beta and a decrease in alpha activity as well as a slowing of the delta/theta centroid and an acceleration of the alpha and beta centroid, which suggests vigilance decrements. In the alpha asymmetry index, they showed right frontal hyper- and left frontal hypoactivation correlated with the Hamilton Depression Score (HAMD). LORETA predominantly revealed decreased power in the theta and alpha-1 frequency band. Negative correlations between theta power and the HAMD were observed in the ventro-medial PFC, the bilateral rostral anterior cingulate cortex (ACC) and the left insular cortex; between alpha-1 power and the HAMD in the right PFC. In the EEG mapping of antidepressants, 20 mg CIT showed mainly activating, 75 mg IMI partly sedative properties. LORETA revealed that CIT increased alpha-2, beta-1, beta-2 and beta-3 power more over the right than over the left hemisphere. However, also a left temporal and frontal delta increase was observed. In conclusion, EEG topography and tomography of depressed menopausal patients demonstrated a right frontal hyper- and left frontal hypoactivation in the alpha asymmetry index as well as a vigilance decrease, with a right-hemispheric preponderance. Within antidepressants at least 2 subtypes may be distinguished from the electrophysiological point of view, a non-sedative and a sedative. LORETA identifies cerebral generators responsible for the pathogenesis of depression as well as for the mode of action of antidepressants.

[1]  A. Hunter,et al.  Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression , 2009, Clinical Neurophysiology.

[2]  H. Semlitsch,et al.  Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with transdermal oestradiol therapy in menopausal depression , 1995, Psychopharmacology.

[3]  P. Anderer,et al.  Comparative pharmacodynamic studies with the novel serotonin uptake-enhancing tianeptine and — inhibiting fluvoxamine utilizing EEG mapping and psychometry , 2005, Journal of Neural Transmission.

[4]  B. Saletu,et al.  On central effects of serotonin re-uptake inhibitors: Quantitative EEG and psychometric studies with sertraline and zimelidine , 2005, Journal of Neural Transmission.

[5]  J. Lind,et al.  A source-imaging (low-resolution electromagnetic tomography) study of the EEGs from unmedicated males with depression , 2004, Psychiatry Research: Neuroimaging.

[6]  D. Pizzagalli,et al.  Functional but not structural subgenual prefrontal cortex abnormalities in melancholia , 2004 .

[7]  Marco Congedo,et al.  Low-resolution electromagnetic tomography (LORETA) of cerebral activity in chronic depressive disorder. , 2003, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[8]  N. Passynkova,et al.  EEG mapping in seasonal affective disorder. , 2002, Journal of affective disorders.

[9]  R. Davidson,et al.  Depression: perspectives from affective neuroscience. , 2002, Annual review of psychology.

[10]  R D Pascual-Marqui,et al.  Structural and energetic processes related to P300: LORETA findings in depression and effects of antidepressant drugs. , 2002, Methods and findings in experimental and clinical pharmacology.

[11]  Roberto D. Pascual-Marqui,et al.  Low Resolution Brain Electromagnetic Tomography (LORETA) , 1997 .

[12]  R. Pascual-Marqui Review of methods for solving the EEG inverse problem , 1999 .

[13]  J C Mazziotta,et al.  Automated labeling of the human brain: A preliminary report on the development and evaluation of a forward‐transform method , 1997, Human brain mapping.

[14]  C. Tenke,et al.  Abnormality of EEG alpha asymmetry in female adolescent suicide attempters , 1996, Biological Psychiatry.

[15]  T. Spector,et al.  European Consensus Development Conference on menopause , 1996 .

[16]  H. Semlitsch,et al.  Hormonal, syndromal and EEG mapping studies in menopausal syndrome patients with and without depression as compared with controls. , 1996, Maturitas.

[17]  N. Rojansky,et al.  Estrogen augments serotonergic activity in postmenopausal women , 1995, Biological Psychiatry.

[18]  Y. Ohashi [The baseline EEG traits and the induced EEG changes by chronic antidepressant medication in patients with major depression. Early prediction of clinical outcomes solely based on quantification and mapping of EEG]. , 1994, Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica.

[19]  G. Gonzales,et al.  Blood serotonin levels in postmenopausal women: effects of age and serum oestradiol levels. , 1993, Maturitas.

[20]  K. K. Tan,et al.  The spatial location of EEG electrodes: locating the best-fitting sphere relative to cortical anatomy. , 1993, Electroencephalography and clinical neurophysiology.

[21]  P. Kaufert,et al.  The Manitoba Project: a re-examination of the link between menopause and depression. , 2008, Maturitas.

[22]  Bernd Saletu,et al.  Artifact processing in topographic mapping of electroencephalographie activity in neuropsychopharmacology , 1992, Psychiatry Research: Neuroimaging.

[23]  H. Semlitsch,et al.  PHARMACODYNAMICS OF VENLAFAXINE EVALUATED BY EEG BRAIN MAPPING, PSYCHOMETRY AND PSYCHOPHYSIOLOGY. , 1992, British journal of clinical pharmacology.

[24]  M. Hunter,et al.  The south-east England longitudinal study of the climacteric and postmenopause. , 1992, Maturitas.

[25]  Jeffrey B. Henriques,et al.  Left frontal hypoactivation in depression. , 1991, Journal of abnormal psychology.

[26]  Karl J. Friston,et al.  Comparing Functional (PET) Images: The Assessment of Significant Change , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[27]  S. Pappatà,et al.  Left prefrontal glucose hypometabolism in the depressed state: a confirmation. , 1990, The American journal of psychiatry.

[28]  M. Hunter Emotional well-being, sexual behaviour and hormone replacement therapy. , 1990, Maturitas.

[29]  M. Torrens Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268 , 1990 .

[30]  R. Davidson,et al.  Regional brain electrical asymmetries discriminate between previously depressed and healthy control subjects. , 1990, Journal of abnormal psychology.

[31]  J. Mazziotta,et al.  Reduction of prefrontal cortex glucose metabolism common to three types of depression. , 1989, Archives of general psychiatry.

[32]  P. Boyer,et al.  Platelet serotonin content and plasma tryptophan in peri‐ and postmenopausal women: variations with plasma oestrogen levels and depressive symptoms , 1988 .

[33]  M. Browning,et al.  Hormone profiles and psychological symptoms in peri-menopausal women. , 1987, Maturitas.

[34]  B Saletu,et al.  Topographic brain mapping of EEG in neuropsychopharmacology--Part I. Methodological aspects. , 1987, Methods and findings in experimental and clinical pharmacology.

[35]  J Grünberger,et al.  Topographic brain mapping of EEG in neuropsychopharmacology--Part II. Clinical applications (pharmaco EEG imaging). , 1987, Methods and findings in experimental and clinical pharmacology.

[36]  H. Hippius,et al.  Pathological cerebral blood flow during motor function in schizophrenic and endogenous depressed patients , 1986, Biological Psychiatry.

[37]  J C Mazziotta,et al.  Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18. , 1985, Archives of general psychiatry.

[38]  B. Saletu,et al.  Classification and determination of cerebral bioavailability of fluoxetine: pharmacokinetic, pharmaco-EEG, and psychometric analyses. , 1985, The Journal of clinical psychiatry.

[39]  B. Saletu,et al.  On acute and chronic CNS effects of antidepressants in normals: neurophysiological, behavioral and pharmacokinetic studies with pirlindol. , 1985, Methods and findings in experimental and clinical pharmacology.

[40]  P. Ekman,et al.  Approaches To Emotion , 1985 .

[41]  Mental Disease,et al.  Brain imaging and brain function , 1985 .

[42]  B. Saletu,et al.  Early clinical pharmacological studies with sercloremine—a novel antidepressant—utilizing pharmacokinetic, pharmaco‐EEG, and psychometric analyses , 1985 .

[43]  E. Metter,et al.  Patterns of cerebral glucose utilization in depression, multiple infarct dementia, and Alzheimer's disease. , 1985, Research publications - Association for Research in Nervous and Mental Disease.

[44]  D. Asso The Real Menstrual Cycle , 1984, British Journal of Psychiatry.

[45]  N. Fox,et al.  Hemispheric asymmetry and emotion , 1984 .

[46]  B. Saletu,et al.  [Classification and determination of the pharmacodynamics of a new tetracyclic antidepressive agent, pirlindol, using pharmaco-EEG and psychometry]. , 1983, Wiener Klinische Wochenschrift.

[47]  B. Saletu,et al.  Pharmaco-EEG profiles of antidepressants. Pharmacodynamic studies with fluvoxamine. , 1983, British journal of clinical pharmacology.

[48]  J. Mann,et al.  Altered platelet serotonin uptake kinetics in schizophrenia and depression. , 1982, Life sciences.

[49]  Edward M. Cross,et al.  Use of the Binomial Theorem in Interpreting Results of Multiple Tests of Significance , 1982 .

[50]  B. Saletu,et al.  The pharmacokinetics of nomifensine. Comparison of pharmacokinetics and pharmacodynamics using computer pharmaco-EEG. , 1982, International pharmacopsychiatry.

[51]  B. Saletu Pharmaco-EEG profiles of typical and atypical antidepressants. , 1982, Advances in biochemical psychopharmacology.

[52]  E. Costa,et al.  Typical and atypical antidepressants. Clinical practice. , 1982, Advances in biochemical psychopharmacology.

[53]  J. P. Ary,et al.  Location of Sources of Evoked Scalp Potentials: Corrections for Skull and Scalp Thicknesses , 1981, IEEE Transactions on Biomedical Engineering.

[54]  F. Duffy,et al.  Significance probability mapping: an aid in the topographic analysis of brain electrical activity. , 1981, Electroencephalography and clinical neurophysiology.

[55]  J. Coope Is oestrogen therapy effective in the treatment of menopausal depression? , 1981, The Journal of the Royal College of General Practitioners.

[56]  D. Broverman,et al.  Estrogen therapy for severe persistent depressions in women. , 1979, Archives of general psychiatry.

[57]  T. Bäckström Estrogen and Frogesterone in Relation to Different Acttvities in the Central Nervous System , 1977 .

[58]  T. Bäckström Estrogen and progesterone in relation to different activities in the central nervous system. , 1977, Acta obstetricia et gynecologica Scandinavica. Supplement.

[59]  M. Aylward Estrogens, plasma tryptophan levels in perimenopausal patients , 1976 .

[60]  W. Utian Definitive symptoms of post-menopause--incorporating use of vaginal parabasal cell index. , 1975, Frontiers of hormone research.

[61]  M. Aylward,et al.  Plasma-tryptophan levels in depression. , 1973, Lancet.

[62]  A. Luria The Working Brain , 1973 .